4-methoxyamphetamine has been researched along with Anterior Horn Cell Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Harris, DA; Jack, K; Wibberley, C | 2 |
Harris, DA | 2 |
Campbell, C; O'brien, T; Oliver, DJ; Sloan, R; Sykes, N; Tallon, C; Taylor-Horan, J; Udoma, M | 1 |
Ahtoniemi, T; Goldsteins, G; Kanninen, K; Keksa-Goldsteine, V; Koistinaho, J; Malm, T; Salminen, A | 1 |
Bach, JR; DeLisa, JA; Francis, K | 1 |
1 review(s) available for 4-methoxyamphetamine and Anterior Horn Cell Disease
Article | Year |
---|---|
Evaluation and rehabilitation of patients with adult motor neuron disease.
Topics: Activities of Daily Living; Adult; Amyotrophic Lateral Sclerosis; Communication; Death; Female; Humans; Male; Motor Neuron Disease; Psychology, Social | 1999 |
6 other study(ies) available for 4-methoxyamphetamine and Anterior Horn Cell Disease
Article | Year |
---|---|
The need to consider 'temporality' in person-centred care of people with motor neurone disease.
Topics: Anxiety Disorders; Caregivers; Death; Humans; Motor Neuron Disease; Qualitative Research | 2023 |
Interpreting end-of-life experiences of the person with motor neurone disease.
Topics: Death; Humans; Motor Neuron Disease | 2022 |
Interpreting end-of-life experiences of the person with motor neurone disease - ERRATUM.
Topics: Death; Humans; Motor Neuron Disease | 2022 |
Making her end of life her own: further reflections on supporting a loved one with motor neurone disease.
Topics: Anthropology, Cultural; Death; Home Care Services; Humans; Motor Neuron Disease; Terminal Care | 2019 |
Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Analgesics, Opioid; Anti-Anxiety Agents; Cholinergic Antagonists; Death; Female; Hospices; Humans; Ireland; Male; Midazolam; Middle Aged; Motor Neuron Disease; Palliative Care; Retrospective Studies; United Kingdom | 2010 |
Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis.
Topics: Animals; Animals, Genetically Modified; Antioxidants; Death; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Humans; Motor Neuron Disease; Neuroglia; Pyrrolidines; Rats; Superoxide Dismutase; Survival Rate; Thiocarbamates | 2007 |